Breaking Finance News

Advantest Corp (ADR) (NASDAQ:ATEYY) has been downgraded to Sell in a statement by Zacks Investment Research earlier today.

Having a price of $16.68, Advantest Corp (ADR) (NASDAQ:ATEYY) traded 0.30% higher on the day. With the last close up 0.00% from the two hundred day average, compared with the S&P 500 Index which has increased 0.05% over the same period. Advantest Corp (ADR) has recorded a 50-day average of $0.00 and a two hundred day average of $0.00. Volume of trade was up over the average, with 103 shares of ATEYY changing hands over the typical 0

Zacks Investment Research has downgraded Advantest Corp (ADR) (NASDAQ:ATEYY) to Sell in a statement released on 7/6/2017.

Performance Chart

Advantest Corp (ADR) (NASDAQ:ATEYY)

With a total market value of $0, Advantest Corp (ADR) has with a one year low of $13.02 and a one year high of $19.64 .

More About Advantest Corp (ADR) (NASDAQ:ATEYY)

Advantest Corporation manufactures and sells semiconductor and component test system products and mechatronics-related products, such as test handlers and device interfaces. The Company engages in research and development activities, and provides maintenance and support services associated with these products. It operates in three segments: semiconductor and component test systems, which provides customers with test system products for semiconductor industry and electronic parts industry; mechatronics systems, which provides product lines, such as test handlers, mechatronic-applied products, for handling semiconductor devices and device interfaces that serve as interfaces with the devices that are measured and operations related to nano-technology products, and services, support and others, which consists of customer solutions provided in connection with semiconductor and component test system and mechatronics system segment, support services, equipment lease business and others.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *